Delivery Order SPE2DB22D1202-SPE2DB24FVMJ1

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,532.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of WEGOVY 0.5 mg/0.5 ml pens, a pharmaceutical product, to support DLA's medical supply requirements. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The award, valued at $2,261.41, is a firm-fixed-price delivery order with an ultimate completion date of August 30, 2024. This contract is not associated with any set-aside program. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts to supply a wide...
This federal contract award, valued at $1,956.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 22, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and...
This federal contract award, valued at $3,710.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $19,267.27 firm-fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans'...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order contract with a ceiling value of $36,625.63. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 4, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical...
This federal contract award, valued at $11,426.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is a Delivery Order under DLA's Indefinite Delivery Contract (IDC) for providing pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will deliver the WEGOVY 0.5...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $2,374.92 for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance ending on September 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to support various...
This federal contract award, valued at $1,935.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of August 16, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $5,501.88 Firm Fixed Price Delivery Order for WEGOVY 1 MG/0.5 ML PEN 0.5ML, placed by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a wide range of...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVMJ1
    Delivery Order

This federal contract award, valued at $15,024.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract involves the delivery of WEGOVY 0.5 mg/0.5 ml pens, which are likely a specialty pharmaceutical product. The contract has a firm fixed price and is set to be completed by September 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to supply a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other federal healthcare programs. This particular award does not have a set-aside designation.

Generated 11/29/24, 9:04 AM